Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
For the LEAD-2 Study Group Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: The LEAD (liraglutide effect and action in diabetes)-2 study
doi: 10.1016/j.pnpbp.2020.109951 444 R.a.P
Alternative delivery formats have also emerged
Future Potential : The robust pipeline of increasingly effective agents, combined with emerging oral formulations and potential cost reduction strategies, suggests that current limitations may be surmountable with continued innovation and policy development
US$ 27.83
US$ 23.63
US$ 22.85
US$ 29.19
US$ 26.19
